A whole of population retrospective observational study on the rates of polypharmacy in New Zealand 2014 to 2018 Polypharmacy in New Zealand: What is the current status?

Health Sci Rep · 2021 · PMC7945953 · PMID 33732897

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a slightly increasing trendno p-value reported

In 2014, the best practice advocacy center New Zealand (bpac nz ) reported a slightly increasing trend (9.8%‐11.1% and 2.2%‐2.6% in polypharmacy and hyper‐polypharmacy, respectively) over the 5‐year period from 2009/10 to 2013/14 in the proportion of New Zealand patients having polypharmacy. 13 In 2017, the Health Quality and Safety Commission of New Zealand found that 33% of the elderly population used five or more long‐term medicines.

also in 801 other papers

an increasing trendno p-value reported

There was an increasing trend in both the rates of polypharmacy and hyper‐polypharmacy as age increased (Tables 1 and 2 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.